Literature DB >> 10633851

Role of chemotherapy in relapsed ovarian cancer.

N Colombo1, G Parma, L Bocciolone, M Sideri, D Franchi, A Maggioni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10633851     DOI： 10.1016/s1040-8428(99)00049-9

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  2 in total

1.  POU4F2/Brn-3b transcription factor is associated with survival and drug resistance in human ovarian cancer cells.

Authors:  Lauren J Maskell; Anupam V Mahadeo; Vishwanie S Budhram-Mahadeo
Journal:  Oncotarget       Date:  2018-12-04

2.  Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer.

Authors:  G D'Agostino; G Ferrandina; M Ludovisi; A Testa; D Lorusso; N Gbaguidi; E Breda; S Mancuso; G Scambia
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.